Biofluid-Triggered Drug for Dual-Enhanced Cancer Therapy #sciencefather #PrecisionChemotherapy
The Microliter-Scale Ethanol Confinement Array with Biofluidic Triggered Release presents a cutting-edge platform for precision chemotherapy. This innovation enables controlled, biofluid-activated release of ethanol at the microscale to enhance drug penetration and therapeutic efficacy. By combining localized ethanol exposure with chemotherapeutic agents, it achieves dual-enhancement—boosting treatment precision while minimizing systemic toxicity, making it a promising tool in advanced cancer therapy. Visit Our Website : http://biotechnologyscientist.com Contact Us : support@biotechnologyscientist.com Nomination Link : https://biotechnologyscientist.com/award-nomination/?ecategory=Awards&rcategory=Awardee #PrecisionChemotherapy #SmartDrugDelivery #BiofluidicSystems #EthanolTriggeredRelease #Microfluidics #CancerTreatmentInnovation #TargetedTherapy #OncologyResearch #ControlledReleaseSystem #Nanomedicine #TumorTargeting #AdvancedChemotherapy #MicroScaleDelivery #BioresponsiveMaterials #DrugPenetration #Theranostics #CancerTech #BiomedicalEngineering #NextGenOncology #SmartChemotherapy
Comments
Post a Comment